10 Best Performing Pharma Stocks in 2025

In this article, we will look at the 10 Best Performing Pharma Stocks in 2025.On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook. He stated that M&A activity started off strong in the year, and that pharma stocks are set to take off in 2026.In addition to the big pharma companies, he believes that biotech, which had a really tough past 3-4 years, is ready to take of ...